Showing results (11-20 of 195) with videos related to
Sort By:
Pageof 20
Kidney & Blood Pressure Research|October 14, 2000
New developments in clinical immunosuppressionB Watschinger, C Wenter, D DemetriouCurrent Opinion in Nephrology and Hypertension|May 1, 1996
Immunomodulatory function of major histocompatibility complex-derived peptidesB Murphy, M H SayeghClinical and Experimental Rheumatology|November 21, 2007
The evolution of the immunobiology of co-stimulatory pathways: clinical implicationsS Trikudanathan, M H SayeghExpert Opinion on Investigational Drugs|November 4, 2000
CTLA4-Ig: a novel immunosuppressive agentN Najafian, M H SayeghCurrent Opinion in Immunology|November 22, 1997
Peptide-mediated immunosuppressionC C Magee, M H SayeghPostgraduate Medical Journal|July 1, 1997
Maintenance pharmacological immunosuppressive strategies in renal transplantationJ P Vella, M H SayeghInternational Reviews of Immunology|January 1, 1996
Role of indirect allorecognition in allograft rejectionM H Sayegh, C B CarpenterKidney International. Supplement|January 1, 1996
Novel immunotherapeutic strategies using MHC derived peptidesM H Sayegh, A M KrenskyAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 20, 1998
Interactions between cyclosporine and newer antidepressant medicationsJ P Vella, M H SayeghJournal of the American Society of Nephrology : JASN|October 1, 1995
T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance inductionM H Sayegh, L A TurkaPageof 20